In short: His illustration of deficit lock-in: "Coca-Cola is building capacity to service a growing deficit." If spending stopped, it "would now have excess capacity and pricing implodes," so "we can't stop spending." An example of the macro argument, not a stock call.
35:44Coca-Cola is building capacity to service a growing deficit. And this is why. If you take our deficit right now and you divide it by the number of people in the United States, each individual is receiving net of, well, it's our deficit, is $7,000. That's what you're getting, $7,000. And now people are very upset because they can't make the ends meet.
In short: The one Morgan Stanley pick he works through himself — and declines. "You have Coca-Cola here, which MS thinks has 13% upside despite the GLP-1 fears. … KO closed at 82.29… has a dividend yield of about 2.4%, but it's a growing dividend and it has free cash flow generation of about 12 to 14 billion a year… if you take 13 billion on 379, that's a three and a half percent free cash yield. So it's not glaringly cheap, but it has sold off pretty dramatically from local highs… in the low to mid 90s. Hasn't sold off as much as I would have liked, but it has pulled back more than the S&P." In Q&A he ranks it above McDonald's — "Coca-Cola is still doing well because Diet Coke sales are still doing well" — and then: "I'm not going to be buying McDonald's or Coca-Cola, but I do think that they are more defensive names."
Coca-Cola is the classic defensive stock: people keep buying drinks in a recession, and the company has raised its dividend for decades. Morgan Stanley thinks it has 13% upside even with the worry that weight-loss drugs will reduce how much sugary drink people consume.
Singh does the check himself. The company generates about $13 billion of free cash a year on a market value of about $379 billion — a 3.5% cash yield, plus a growing 2.4% dividend. That is solid, "not glaringly cheap." The shares have fallen from the low-to-mid $90s to about $82, but not as far as he would like before buying. He rates it a better defensive holding than McDonald's, because Diet Coke is selling well while fast-food visits are being hurt by the same drugs — but he is not buying either right now.
Full passage: premium transcript (PDF).
In short: Named in the same GLP-1-casualty list. Belski: "Then you can throw in Mondelez. Let's throw in Coca-Cola. Let's throw in General Mills… people are not eating those names." He offers it as a reductio — if GLP-1s explain quick-serve, they explain staples too — but does not dispute that the group has de-rated, and Lebenthal agrees it "has been nauseous."
Coca-Cola is named in the same list, for the same reason. It is a defensive, dividend-paying business that would normally be a safe place to sit while the market worries about rates — and it has not behaved like one.
The useful thing here is not the stance, which is thin, but the question the exchange leaves unanswered: whether a structural fall in calorie consumption is a permanent headwind for the staples group, or whether the de-rating is about something more ordinary like bond yields making dividend stocks less attractive. Nobody on the desk tests it.
In short: The other Halo spotlight, and the one that draws a real argument. Brown: "the second quarter report was the cleanest print for Coke we've seen in a long time — net revenue up 7% to $13.5B, organic revenue up 6%, gross margins 62.9%. I guess the GLP-1s haven't stopped people from drinking this stuff." The driver: the FIFA World Cup produced "the strongest trademark Coca-Cola volume growth in 17 years, up 5%, Powerade up 8," and management raised guidance — "everything that we want to see. This is a stock that probably continues to make new highs… I think we'll see 100 bucks." His invalidation level is explicit: 77, the March shakeout low — "if we break that level, the buyers have changed their minds. They're not coming back." Sechan (long-time owner): "enormous pricing power, great brand portfolio, really benefited from the World Cup… a 2.3% dividend yield… incredibly strong, and has the tailwinds of being the other side of the barbell versus what has been working of late." Harrington dissents on price: "the yield's a little too low, but not a lot too low… what holds me really at bay on Coke is it's just expensive — 7% earnings growth and it's still trading at 27 times earnings. Frankly, you can look at the Mag 7 and find a far more compelling combination." Her second objection is the consumer: "if you do worry about the K-shaped consumer, there's a huge percentage of people who drink Coke and Dasani and Powerade who will be under pressure."
Coca-Cola's last quarter was, in Brown's words, its cleanest report in a long time: revenue up 7%, growth of 6% before currency and acquisitions are counted, and gross margins near 63%. The World Cup produced the best volume growth for the core Coke brand in 17 years. Management raised its forecast. He thinks the stock keeps making new highs and gets to $100, and he names 77 as the level that would prove him wrong.
Rob Sechan owns it for a different reason: pricing power, a broad portfolio of brands and a 2.3% dividend, which makes it "the other side of the barbell" — the thing you hold against the AI trade, not alongside it.
Jenny Harrington argues the other way and her objection is purely arithmetic. Coke is growing earnings about 7% a year and trades at 27 times earnings; for that price she thinks you can buy faster-growing businesses. Her second worry is who actually drinks the products: if the economy is splitting between comfortable and squeezed households, a large share of Coke's customers are in the squeezed half. She also mentions weight-loss drugs as a bigger threat to Pepsi, because of its snack business, than to Coke.
In short: Named as a company that dropped out of the top twenty — nineteenth at $95.90bn in 2005 — with the explicit qualification that this is not a criticism: "Companies like Coca-Cola and Home Depot are still exceptional businesses today. However, they no longer make the list." Argued positively as #10 on the Lindy list four days earlier.
In short: #10. Founded 1886, IPO 1919. The asset-light structure is the point: "They sell concentrates and syrups to restaurants and independent bottling companies" — the capital-intensive bottling sits with third parties. Lindy case: "People will always want sweet drinks… Its global distribution network is nearly impossible to copy." Compounded at more than 10% a year since 1990, nearly 4,000% in total. The founding detail is left in: John Pemberton's syrup "originally contained small amounts of cocaine (!) and was marketed as a pain reliever."
Coca-Cola does not really make fizzy drinks. It makes the concentrated syrup and sells it to independent bottlers, who buy the factories, the cans and the delivery trucks and take all the capital risk. Coca-Cola keeps the recipe, the brand and the marketing — which is where nearly all the profit is.
The durability case is that sweet drinks are not a fashion, the brand is among the most recognised objects on earth, and a distribution system that reaches roughly every shop in every country took a century to assemble. The shares have compounded at more than 10% a year since 1990, close to 4,000% in total. The origin story is left in for colour: a pharmacist's 1886 syrup that contained a little cocaine and was sold as a pain remedy.
In short: Named by Brown as one of the Berkshire equity holdings that "happen to be a lot of the stocks that are working in this tape" — part of why Berkshire has worked this year. No stance on Coca-Cola itself.
In short: Volume carries the quarter. Q2 revenue +7% Y/Y to $13.4B ($230M beat) and comparable EPS +11% to $0.97 ($0.04 beat), with organic revenue +6% against a ~3.6% consensus; the stock jumped ~5% to a fresh high, up more than 20% this year, after absorbing a shipment-timing drag. Volume did the work: global unit case volume +5%, positive in every segment, led by India, China, the US and Brazil, while price/mix added just 2% on CEO Henrique Braun's affordability-over-pricing pivot. Zero Sugar +16% and Diet Coke +7%; the FIFA World Cup sponsorship lifted Trademark Coca-Cola volume 5% and Powerade 8%. Comparable operating margin expanded to 35.6% from 34.7% despite the affordability drag. FY26 comparable EPS growth raised to 9%–10% (from 8%–9%) with organic revenue growth now ~5% (vs ~4.6% consensus). Headwinds in the back half: six fewer shipping days in Q4 and the CCBA (Coca-Cola Beverages Africa) divestiture, framed as a 2%–3% revenue headwind closing late Q3 or Q4. With price/mix deliberately at 2%, volume is the lever. (Recap, not a stance call.)
For years consumer-goods companies grew by raising prices while selling fewer units. Coca-Cola is deliberately doing the opposite: it held price increases to just 2% and let volume do the work — 5% more drinks sold, growth in every region, led by India, China, the US and Brazil. That's a healthier kind of growth, because it means people are actually buying more rather than paying more for less. Remarkably, profit margins still widened, and the World Cup sponsorship lifted core Coke and Powerade volumes. The stock hit a new high. Two known drags are coming: six fewer shipping days in the fourth quarter, and the sale of its African bottling arm, worth a 2–3% hit to reported revenue. With price growth capped on purpose, volume has to keep carrying it. A recap, not a call.
In short: Simpson's conviction beverage name over Pepsi: a huge position in the dividend portfolio, +20% on the year. "I like Coke" — where his conviction sits vs the downgraded PEP.
Faced with a choice between the two beverage giants, Kevin Simpson's conviction is firmly with Coca-Cola over Pepsi. It's a large position in his dividend portfolio and is up 20% this year. The contrast is the point: while Pepsi's North American demand is weak and it's being downgraded, Coke is executing — so he's happy to hold the winner and avoid the laggard.
In short: Passing example, not a call: Buffett & Munger's Coca-Cola dividends "far exceeded their initial investment after 10 or 15 years" — his illustration of letting time and compounding work rather than chasing a quick double.
30:05The dividends they were getting far exceeded their initial investment after 10 or 15 years but people don't want to utilize time, they want to get rich quick. I think it was — who was it, something, not Upton, I can't remember his name — it was a guy in England in the late 1800s. This is the problem with most investors. They just want to get rich quick. This is the bottom line and that's not how you get rich. It's very possible to use these markets as a tool to get rich, but you're not going to get rich quick.
In short: Passing reference — named as an example of a tiered World Cup sponsor inside FIFA's ~$3.3B (25%) Marketing & Sponsorship stream. Author discloses owning none of the stocks.
In short: Named twice as illustration, not as a pick: as the evidence that Berkshire lets winners run — "Warren Buffett started buying Coca-Cola in 1988" and it "performed exceptionally well" — and as one of the Nifty Fifty names (with IBM, Xerox and Polaroid) showing that 1960s index concentration spanned unrelated industries.
In short: Valuation benchmark — PEP's "chief rival"; KO trades at almost 24× earnings, and PEP "often traded at parity with Coke's multiple" historically, so the gap is the re-rating opportunity for PEP (not a call on KO itself).
Nothing matches this filter.
Verbatim excerpts from the public transcripts (auto-pulled at each mention's timestamp, lightly cleaned). Timestamps link into the video; "source page" opens that commentator's full analysis at this row. Click a mention's header line to expand it (one open at a time). For personal study — not investment advice.